1. Home
  2. PVLA vs PBFS Comparison

PVLA vs PBFS Comparison

Compare PVLA & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • PBFS
  • Stock Information
  • Founded
  • PVLA 2015
  • PBFS 1889
  • Country
  • PVLA United States
  • PBFS United States
  • Employees
  • PVLA N/A
  • PBFS N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • PBFS Banks
  • Sector
  • PVLA Health Care
  • PBFS Finance
  • Exchange
  • PVLA Nasdaq
  • PBFS Nasdaq
  • Market Cap
  • PVLA 308.2M
  • PBFS 309.6M
  • IPO Year
  • PVLA N/A
  • PBFS N/A
  • Fundamental
  • Price
  • PVLA $23.59
  • PBFS $11.56
  • Analyst Decision
  • PVLA Strong Buy
  • PBFS
  • Analyst Count
  • PVLA 6
  • PBFS 0
  • Target Price
  • PVLA $43.50
  • PBFS N/A
  • AVG Volume (30 Days)
  • PVLA 93.0K
  • PBFS 18.9K
  • Earning Date
  • PVLA 05-15-2025
  • PBFS 05-12-2025
  • Dividend Yield
  • PVLA N/A
  • PBFS N/A
  • EPS Growth
  • PVLA N/A
  • PBFS 11.77
  • EPS
  • PVLA N/A
  • PBFS 0.76
  • Revenue
  • PVLA N/A
  • PBFS $88,118,000.00
  • Revenue This Year
  • PVLA N/A
  • PBFS N/A
  • Revenue Next Year
  • PVLA N/A
  • PBFS N/A
  • P/E Ratio
  • PVLA N/A
  • PBFS $15.41
  • Revenue Growth
  • PVLA N/A
  • PBFS 21.67
  • 52 Week Low
  • PVLA $6.20
  • PBFS $8.76
  • 52 Week High
  • PVLA $29.27
  • PBFS $12.20
  • Technical
  • Relative Strength Index (RSI)
  • PVLA N/A
  • PBFS 42.83
  • Support Level
  • PVLA N/A
  • PBFS $11.49
  • Resistance Level
  • PVLA N/A
  • PBFS $11.78
  • Average True Range (ATR)
  • PVLA 0.00
  • PBFS 0.20
  • MACD
  • PVLA 0.00
  • PBFS -0.05
  • Stochastic Oscillator
  • PVLA 0.00
  • PBFS 12.50

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.

About PBFS Pioneer Bancorp Inc.

Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.

Share on Social Networks: